The Sulfasalazine Tablets, cataloged under National Stock Number 6505-01-174-4988, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Consolidated Midland Corp. Government technical data includes 4 specifications, cited from the U.S. Government catalog. The record lists 4 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. Current acquisition status: Active.
| Parameter | Value |
|---|---|
| NSN | 6505-01-174-4988 |
| Primary Part Number | NDC00223-1727-02 |
| Item Name | Sulfasalazine Tablets |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Consolidated Midland Corp |
| Status | ACTIVE |
| Primary Container Content Quantity | 1000.000 TABLETS |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | BOTTLE |
| Active Medicament Medicinal Strength | 500.000 MILLIGRAMS SULFASALAZINE ACTIVE INGREDIENT |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Part Number | Manufacturer |
|---|---|
| NDC00223-1727-02 PRIMARY | Consolidated Midland Corp (USA) |
| 01-7013 PRIMARY | Goldline Laboratories, Inc. Dba Goldline Laboratories (USA) |
| NDC00032-2060-10 PRIMARY | Solvay Pharmaceuticals, Inc. (USA) |
| NDC00182-1016-10 PRIMARY | Goldline Laboratories, Inc. Dba Goldline Laboratories (USA) |
NSN 6505-01-174-4988 is a Sulfasalazine Tablets, manufactured by Consolidated Midland Corp, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-174-4988 has 4 manufacturer part numbers on file: NDC00223-1727-02 (Consolidated Midland Corp), 01-7013 (Goldline Laboratories, Inc. Dba Goldline Laboratories), NDC00032-2060-10 (Solvay Pharmaceuticals, Inc.), NDC00182-1016-10 (Goldline Laboratories, Inc. Dba Goldline Laboratories).
Key specifications for NDC00223-1727-02: Primary Container Content Quantity: 1000.000 TABLETS; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Type: BOTTLE; Active Medicament Medicinal Strength: 500.000 MILLIGRAMS SULFASALAZINE ACTIVE INGREDIENT. 4 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.